Ofir Cohen
Harvard University
H-index: 33
North America-United States
Top articles of Ofir Cohen
Author Correction: Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
Nature Cell Biology
2024/3/5
Abstract PD10-03: PD10-03 Super-enhancer-oriented integrative bioinformatics identifies aberrant KLF4 signaling in endocrine-resistant breast cancer (BC)
Cancer Research
2023/3/1
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
Cell Reports
2023/8/29
Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer
Science advances
2023/5/26
Ofir Cohen
H-Index: 21
Mutated HRAS activates YAP1–AXL signaling to drive metastasis of head and neck cancer
Cancer research
2023/4/4
Ofir Cohen
H-Index: 21
SlideCNA: Spatial copy number alteration detection from Slide-seq-like spatial transcriptomics data
bioRxiv
2022/11/27
Multidimensional molecular profiling of metastatic triple-negative breast cancer and immune checkpoint inhibitor benefit
JCO Precision Oncology
2022/7
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Nature Communications
2022/4/19
Abstract PD6-03: Spatio-molecular dissection of the breast cancer metastatic microenvironment
Cancer Research
2022/2/15
Abstract PD1-05: Targeting the FRA1-dependent transcriptional nexus in high FOXA1-driven endocrine-resistant and metastatic breast cancer
Cancer Research
2022/2/15
Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
Nature medicine
2021/2
Spatially organized multicellular immune hubs in human colorectal cancer
Cell
2021/9/2
Abstract PD8-03: A FOXA1/FRA1-centered transcriptional axis regulates interferon signaling in high FOXA1-associated endocrine-resistant and metastatic breast cancer
Cancer Research
2021/2/15
Abstract OT-18-01: The metastatic breast cancer project: Generating the clinical and genomic landscape of metastatic breast cancer through patient-partnered research
Cancer Research
2021/2/15
Abstract PS4-25: Comprehensive genomic analysis reveals molecular correlates of response to immune checkpoint inhibitors (ICI) in metastatic triple-negative breast cancer (mTNBC)
Cancer Research
2021/2/15
Multicellular immune hubs and their organization in MMRd and MMRp colorectal cancer
bioRxiv
2021/2/1
Abstract PD2-09: The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in patients with hormone receptor-positive (HR+ …
Cancer Research
2020/2/15
Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases
Nature Structural & Molecular Biology
2020/1
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer
Clinical Cancer Research
2020/11/15
Abstract B23: Genomic sequencing of metastatic hormone-receptor positive breast cancer implicates AKT1 in driving resistance to cyclin-dependent kinase 4/6 inhibitors
Molecular Cancer Research
2020/10/1
Ofir Cohen
H-Index: 21
Nikhil Wagle
H-Index: 42